Cargando…
Retracted: CD248 as a novel therapeutic target in pulmonary arterial hypertension
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283842/ https://www.ncbi.nlm.nih.gov/pubmed/34323428 http://dx.doi.org/10.1002/ctm2.488 |
Ejemplares similares
-
CD248 as a novel therapeutic target in pulmonary arterial hypertension
por: Xu, Tao, et al.
Publicado: (2020) -
Retracted: Pulmonary hypertension due to a pulmonary artery leiomyosarcoma: A case report
Publicado: (2015) -
Notice of Retraction: Therapeutic Effects of Umbilical Cord Blood Derived Mesenchymal Stem Cell-Conditioned Medium on Pulmonary Arterial Hypertension in Rats
por: Lee, Jae Chul, et al.
Publicado: (2016) -
Retracted: Prognostic Role of Biomarkers for Pulmonary Arterial Hypertension Associated with Bronchopulmonary Dysplasia in Extremely Premature Infants
por: and Biomechanics, Applied Bionics
Publicado: (2022) -
CD248: A therapeutic target in cancer and fibrotic diseases
por: Teicher, Beverly A.
Publicado: (2019)